Recent

% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • knowtain knowtain Apr 11, 2005 4:44 PM Flag

    challenges

    > Yes, biotech and pharma are the best for investment. But point is AMRI is none of them.
    AMRI is just a contractor, period.

    Pure biopharmas are a gamble. Albany Molecular will be around a while. Pure biopharmas either get bought up or go bankrupt. Albany Molecular has multiple revenue streams with ability to play biopharma game.

    The idea of patent expiration is good for R&D outsources like Albany Molecular in long term. So short term Allegra pain brings long term gain.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • >Albany Molecular has multiple revenue streams with ability to play biopharma game.

      AMRI does not have intellectual and financial resources to be a part of any biotech or pharmaceutical companies.
      AMRI is a contractor for very early stages.

      > The idea of patent expiration is good for R&D outsources like Albany Molecular in long term. So short term Allegra pain brings long term gain.

      You have no clue about patents and how it works.

      From now AMRI has no royalty from Allegra.
      Do you understand what that means for this stock and for the AMRI generally?

      • 2 Replies to peret500
      • peret, you said: �AMRI does not have intellectual and financial resources to be a part of any biotech or pharmaceutical companies.�

        How can you make this statement? You apparently have not read or listened to what has been discussed in earlier posts. The reason that the company exists at all is all because of the intellectual resources that it has. I�ve heard that they built the company from scratch, without any venture money. They did this by providing their chemistry services (problem solving / intellectual resources) for a fee. The fact that the company went public in �99 without venture backing is astounding to me. They must have been doing something right. How did they scoop a big pharma company for the invention of the manufacturing process for Allegra? Stupid? I don�t think so. Could you do that?

        $130 MM in the bank? They have no overhead on the Allegra royalty income. If it goes away, it doesn�t cost them anything.

        �AMRI is a contractor for very early stages.�

        This is vague and not true either. If you read the profile of the company on it�s own web site, it clearly states that it provides a full range of services. They still seem to be a purely chemistry services and development company. Development, in this context, includes process development through manufacturing of the final active ingredient that goes into the pills/capsules. They provide contract research to both biotech and pharma companies. As far as categorizing the company as a biotech, I�m not sure that they actually are. I see nowhere that they have any �bio� component, internally. They specialize in chemistry and solving chemistry problems.

        Bully

      • > AMRI does not have intellectual and financial resources to be a part of any biotech or pharmaceutical companies.
        AMRI is a contractor for very early stages.

        Sounds like peret500 knows much about Albany Molecular. Why keep us in suspense? Tell us why AMRI is such a strong sell. All peret500 has done is insult.

        > From now AMRI has no royalty from Allegra.
        Do you understand what that means for this stock and for the AMRI generally?

        Sounds like peret500 knows how the litigation is going to go. Why bother litigate, let's just listen to wise peret500.

 
AMRI
15.15-0.27(-1.75%)1:06 PMEDT